LaPAroscopic Low pRessure cOlorectal Surgery (PAROS)

October 6, 2020 updated by: University Hospital, Bordeaux
Laparoscopy by its mini-invasive character has revolutionized abdominal and colorectal surgery but certain limitations remains (post-operative pain due to pneumoperitoneum, pneumoperitoneum stability, visibility during bleeding, smoke evacuation). The medical device for continuous pressure insufflation during laparoscopic procedures Airseal® would allow the maintenance of pneumoperitoneum at a lower pressure. The stable low pressure (7mmHg) is described in the literature for 15 years as the best way to reduce scapular pain, but until the marketing of Airseal, working at 7mmHg was not possible because the space of work was not stable. Moreover, this device makes it possible to obtain a better vision because of the evacuation of the fumes potentially leading to a reduction in the operating time.

Study Overview

Status

Completed

Detailed Description

This research focuses on a medical device that allows the surgeon to perform the surgical procedure at a lower pressure than usual.

The main objective of this study is to compare the duration of hospitalization of patients with laparoscopic colectomy at low pressure (5-7 mmHg) versus standard pressure (12-15 mmHg) It is a prospective randomized monocentric double blind study

Study Type

Interventional

Enrollment (Actual)

138

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France
        • CHU de Bordeaux

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 18
  • Colonic resection (right or left) performed for benign or malignant pathology
  • Laparoscopic procedure
  • Informed consent signed
  • Social Insurance

Exclusion Criteria:

  • Laparotomy procedure
  • Associated resection (except appendectomy or liver biopsy
  • Emergency procedure
  • Pelvic sepsis
  • Pregnant or breast-feeding woman.
  • Persons deprived of liberty or under guardianship
  • Impossibility for compliance to follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm A: Low Pressure (5-7 mmHg)
Laparoscopic colectomy surgery with low pressure (5-7mmHg)
Medical device set to the mode Airseal®, pressure adjustment between 5 and 7 mmHg
Active Comparator: Arm B: Standard pressure (12-15 mmHg)
Laparoscopic colectomy surgery with standard pressure (12-15mmHg)
Medical device set to the mode "Standard Insufflation", pressure adjustment between 12 and 15 mmHg

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of postoperative hospital stay
Time Frame: From surgery to the end of the hospitalization (max 30 days)
To determine the length of hospitalization
From surgery to the end of the hospitalization (max 30 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgery time
Time Frame: During surgery
To determine the surgery time
During surgery
Appreciation of visual quality by surgeon
Time Frame: During surgery
To determine the rate of visual quality during surgery: poor, medium or good quality
During surgery
Impact of the use of microlaparoscopic instruments
Time Frame: During surgery
To determine the rate of use of the microsurgery microlaparoscopic instruments (3mm)
During surgery
Rates of conversion
Time Frame: During surgery
Conversion to laparoscopy with standard pressure or conversion to laparotomy
During surgery
Blood pressure (mmHg)
Time Frame: During surgery
To examine the variation of blood pressure during surgery (at the beginning, middle and at the end)
During surgery
Cardiac frequency (/ min)
Time Frame: During surgery
To examine the variation of cardiac frequency during surgery (at the beginning, middle and at the end)
During surgery
Volume replacement (mL)
Time Frame: During surgery
To examine the volume replacement during surgery (at the beginning, middle and at the end)
During surgery
Driving pressure (mmHg)
Time Frame: During surgery
To examine the variation of drinving pressure during surgery (at the beginning, middle and at the end)
During surgery
Oxygen saturation (%)
Time Frame: During surgery
To examine the variation of SA02 (%) during surgery (at the beginning, middle and at the end)
During surgery
Partial pressure of mean expired of carbon dioxide (mmHg)
Time Frame: During surgery
To examine the variation PECO2 (mmHg) during surgery (at the beginning, middle and at the end)
During surgery
Surgical and medical morbidity
Time Frame: From surgery until 30 days (max 45 days)
To analyse the cumulative Clavien-Dindo at 30 days
From surgery until 30 days (max 45 days)
Postoperative pain
Time Frame: 2 hours, 4 hours, 8 hours and 24 hours after the surgery
Pain was evaluated with the Numeric Rating Scale (NRS, from 0 (no pain) to 10 (hurts worst)
2 hours, 4 hours, 8 hours and 24 hours after the surgery
Use of analgesics
Time Frame: An average of 5 days after the surgery
To evaluate the rate of analgesics administrated (from step1 to step3)
An average of 5 days after the surgery
Time before the passage of first stool (days)
Time Frame: An average of 5 days after the surgery
To determine the delay of the laxation and gas response
An average of 5 days after the surgery
Time before the passage of first gas (days)
Time Frame: An average of 5 days after the surgery
To determine the delay of the gas response
An average of 5 days after the surgery
Time before mobilization (Days before 1st time sitting and standing)
Time Frame: An average of 5 days after the surgery
To determine the delay before mobilization
An average of 5 days after the surgery
Quality of cancer surgery
Time Frame: During surgery
Rate of curative surgery (R0)
During surgery
Number of lymph nodes examed
Time Frame: During surgery
Number of lymph nodes examed during a cancer surgery
During surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Quentin DENOST, University Hospital, Bordeaux

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2019

Primary Completion (Actual)

May 25, 2020

Study Completion (Actual)

June 26, 2020

Study Registration Dates

First Submitted

January 8, 2019

First Submitted That Met QC Criteria

January 22, 2019

First Posted (Actual)

January 23, 2019

Study Record Updates

Last Update Posted (Actual)

October 8, 2020

Last Update Submitted That Met QC Criteria

October 6, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • CHUBX 2018/42

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant or Benign Pathology

Clinical Trials on Airseal®

3
Subscribe